{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:54:11Z","timestamp":1790283251877,"version":"4.1.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>We describe the clinical, mycological, immunological, and genetic characteristics of six HIV-negative patients presenting with invasive cryptococcosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients with cryptococcosis without any of the classical risk factors, such as HIV infection, followed at Cayenne Hospital, were prospectively included. An immunologic and genetic assessment was performed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Five male patients and one female patient, 5 adults and one child, were investigated. All presented a neuromeningeal localization.<jats:italic>Cryptococcus neoformans<\/jats:italic>var.<jats:italic>gattii<\/jats:italic>and<jats:italic>C. neoformans<\/jats:italic>var.<jats:italic>grubii<\/jats:italic>were isolated in two and three patients, respectively, whereas one patient could not be investigated. Overall, we did not observe any global leukocyte defect. Two patients were found with high levels of circulating autoantibodies against Granulocyte macrophage-colony stimulating factor (GM-CSF), and none had detectable levels of autoantibodies against Interferon gamma (IFN-\u03b3) Sequencing of<jats:italic>STAT1<\/jats:italic>exons and flanking regions performed for four patients was wild type.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>To better understand cryptococcosis in patients with cryptococcosis but otherwise healthy, further explorations are needed with repeated immune checkups and strain virulence studies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.881352","type":"journal-article","created":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T11:55:57Z","timestamp":1650974157000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Case Report: Invasive Cryptococcosis in French Guiana: Immune and Genetic Investigation in Six Non-HIV Patients"],"prefix":"10.3389","volume":"13","author":[{"given":"Jeanne","family":"Goupil de Bouill\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Epelboin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Henaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Migaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Abboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Blanchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Aznar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Djossou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narcisse","family":"Elenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Puel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Lanternier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magalie","family":"Demar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00311-15","article-title":"Cryptococcosis Serotypes Impact Outcome and Provide Evidence of Cryptococcus Neoformans Speciation","volume":"6","author":"Desnos-Ollivier","year":"2015","journal-title":"mBio"},{"key":"B2","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1439-0507.1989.tb02200.x","article-title":"Cryptococcus Neoformans Var. Gattii Vanbreuseghem and Takashio, 1970","volume":"32","author":"De Vroey","year":"1989","journal-title":"Mycoses"},{"key":"B3","doi-asserted-by":"publisher","first-page":"840452","DOI":"10.1155\/2009\/840452","article-title":"Cryptococcus Gattii: An Emerging Cause of Fungal Disease in North America","volume":"2009","author":"Dixit","year":"2009","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"155\u221268","DOI":"10.1080\/714031012","article-title":"Cryptococcus Neoformans Variety Gattii","volume":"39","author":"Sorrell","year":"2001","journal-title":"Med Mycol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3959\u221266","DOI":"10.4049\/jimmunol.1202526","article-title":"Anti-GM-CSF Autoantibodies in Patients With Cryptococcal Meningitis","volume":"190","author":"Rosen","year":"2013","journal-title":"J Immunol Baltim Md 1950"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00912-14","article-title":"Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies Are a Risk Factor for Central Nervous System Infection by Cryptococcus Gattii in Otherwise Immunocompetent Patients","volume":"5","author":"Saijo","year":"2014","journal-title":"mBio"},{"key":"B7","doi-asserted-by":"publisher","first-page":"4513\u221227","DOI":"10.1128\/IAI.00935-15","article-title":"STAT1 Signaling Within Macrophages Is Required for Antifungal Activity Against Cryptococcus Neoformans","volume":"83","author":"Leopold Wager","year":"2015","journal-title":"Infect Immun"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.654406","article-title":"Clinical Relevance of Gain- and Loss-Of-Function Germline Mutations in STAT1: A Systematic Review","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol 11 mars"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e1\u221219","DOI":"10.1097\/MD.0b013e31825f95b9","article-title":"Autosomal Dominant STAT3 Deficiency and Hyper-IgE Syndrome: Molecular, Cellular, and Clinical Features From a French National Survey","volume":"91","author":"Chandesris","year":"2012","journal-title":"Med (Baltimore)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.07.003","article-title":"Endemic Mycoses in Patients With STAT3 Mutated Hyperimmunoglobulin E (Job\u2019s) Syndrome","volume":"136","author":"Odio","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"373\u221284","DOI":"10.1097\/01.md.0000100046.06009.b0","article-title":"The X-Linked Hyper-IgM Syndrome: Clinical and Immunologic Features of 79 Patients","volume":"82","author":"Winkelstein","year":"2003","journal-title":"Med (Baltimore)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1367\u221276","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"B13","doi-asserted-by":"publisher","first-page":"864\u221271","DOI":"10.3109\/13693786.2011.584198","article-title":"Characteristics and Specificities of Cryptococcus Infections in French Guiana, 1998-2008","volume":"49","author":"Debourgogne","year":"2011","journal-title":"Med Mycol"},{"key":"B14","doi-asserted-by":"crossref","DOI":"10.1016\/j.mycmed.2016.11.001","volume-title":"An Estimation of Burden of Serious Fungal Infections in France","author":"Gangneux","year":"2016"},{"key":"B15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040021","article-title":"French Cryptococcosis Study Group. Determinants of Disease Presentation and Outcome During Cryptococcosis: The CryptoA\/D Study","volume":"4","author":"Dromer","year":"2007","journal-title":"PloS Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"61\u221279","DOI":"10.1371\/journal.pmed.0040021","article-title":"Cryptococcal Infections in Non-HIV-Infected Patients","volume":"124","author":"Pappas","year":"2013","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"B17","doi-asserted-by":"crossref","first-page":"111\u22125","DOI":"10.7883\/yoken.JJID.2008.111","article-title":"Comparison of Clinical Features and Survival Between Cryptococcosis in Human Immunodeficiency Virus (HIV)-Positive and HIV-Negative Patients","volume":"61","author":"Jongwutiwes","year":"2008","journal-title":"Jpn J Infect Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"143\u221251","DOI":"10.1093\/qjmed\/hcl014","article-title":"Cryptococcosis in Apparently Immunocompetent Patients","volume":"99","author":"Lui","year":"2006","journal-title":"QJM Mon J Assoc Phys"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz193","article-title":"A Multicenter, Longitudinal Cohort Study of Cryptococcosis in HIV-Negative People in the United States","volume":"70","author":"Marr","year":"2019","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"B20","doi-asserted-by":"publisher","first-page":"690\u22129","DOI":"10.1086\/322597","article-title":"Cryptococcosis in Human Immunodeficiency Virus-Negative Patients in the Era of Effective Azole Therapy","volume":"33","author":"Pappas","year":"2001","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"B21","doi-asserted-by":"publisher","first-page":"28\u221234","DOI":"10.1093\/clinids\/21.1.28","article-title":"Clinical and Host Differences Between Infections With the Two Varieties of Cryptococcus Neoformans","volume":"21","author":"Speed","year":"1995","journal-title":"Clin Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"935\u221240","DOI":"10.1099\/jmm.0.05427-0","article-title":"Cryptococcus Neoformans Infections at Vancouver Hospital and Health Sciences Centre (1997-2002): Epidemiology, Microbiology and Histopathology","volume":"53","author":"Hoang","year":"2004","journal-title":"J Med Microbiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"511\u22128","DOI":"10.1093\/qjmed\/95.8.511","article-title":"Cryptococcaemia: Clinical Features and Prognostic Factors","volume":"95","author":"Jean","year":"2002","journal-title":"QJM Mon J Assoc Phys"},{"key":"B24","doi-asserted-by":"publisher","first-page":"980\u22121024","DOI":"10.1128\/CMR.00126-13","article-title":"Cryptococcus Gattii Infections","volume":"27","author":"Chen","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"B25","doi-asserted-by":"publisher","first-page":"291\u2212322","DOI":"10.1086\/649858","article-title":"Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"B26","doi-asserted-by":"publisher","first-page":"835\u221246","DOI":"10.1128\/EC.00039-10","article-title":"Cryptococcal Interactions With the Host Immune System","volume":"9","author":"Voelz","year":"2010","journal-title":"Eukaryot Cell"},{"key":"B27","doi-asserted-by":"publisher","first-page":"570\u22129","DOI":"10.3109\/13693780903437876","article-title":"Cryptococcal Meningitis in Non-HIV-Infected Patients in a Chinese Tertiary Care Hospital, 1997\u20132007","volume":"48","author":"Zhu","year":"2010","journal-title":"Med Mycol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076371","article-title":"Autoantibody to Interferon-Gamma Associated With Adult-Onset Immunodeficiency in Non-HIV Individuals in Northern Thailand","volume":"8","author":"Wongkulab","year":"2013","journal-title":"PloS One"},{"key":"B29","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12879-020-4949-4","article-title":"Triple Infection With Cryptococcus, Varicella-Zoster Virus, and Mycobacterium Abscessus in a Patient With Anti-Interferon-Gamma Autoantibodies: A Case Report","volume":"20","author":"Rujirachun","year":"2020","journal-title":"BMC Infect Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"725\u221234","DOI":"10.1056\/NEJMoa1111160","article-title":"Adult-Onset Immunodeficiency in Thailand and Taiwan","volume":"367","author":"Browne","year":"2012","journal-title":"N Engl J Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"78\u221292","DOI":"10.1097\/md.0b013e31803b52f5","article-title":"Cryptococcosis and Idiopathic CD4 Lymphocytopenia","volume":"86","author":"Zonios","year":"2007","journal-title":"Med (Baltimore)"},{"key":"B32","doi-asserted-by":"publisher","first-page":"3154\u221264","DOI":"10.1182\/blood-2015-11-679902","article-title":"Heterozygous STAT1 Gain-of-Function Mutations Underlie an Unexpectedly Broad Clinical Phenotype","volume":"127","author":"Toubiana","year":"2016","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","first-page":"499\u2212508","DOI":"10.1086\/313992","article-title":"Epidemiology and Host- and Variety-Dependent Characteristics of Infection Due to Cryptococcus Neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group","volume":"31","author":"Chen","year":"2000","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"B34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3390\/jof3040062","article-title":"Ecoepidemiology of Cryptococcus Gattii in Developing Countries","volume":"3","author":"Herkert","year":"2017","journal-title":"J Fungi"},{"key":"B35","doi-asserted-by":"publisher","first-page":"639\u221243","DOI":"10.1111\/myc.12210","article-title":"Fatal Cryptococcus Gattii Genotype AFLP6\/VGII Infection in a HIV-Negative Patient: Case Report and a Literature Review","volume":"57","author":"Favalessa","year":"2014","journal-title":"Mycoses"},{"key":"B36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/jof4010032","article-title":"Cryptococcosis in Colombia: Compilation and Analysis of Data From Laboratory-Based Surveillance","volume":"4","author":"Escand\u00f3n","year":"2018","journal-title":"J Fungi Basel Switz"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004598","article-title":"Q Fever in French Guiana: Tip of the Iceberg or Epidemiological Exception","volume":"10","author":"Epelboin","year":"2016","journal-title":"PloS Negl Trop Dis"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1727\u221232","DOI":"10.4269\/ajtmh.17-0609","article-title":"Cryptosporidiosis Outbreak in Immunocompetent Children From a Remote Area of French Guiana","volume":"98","author":"Mosnier","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"B39","doi-asserted-by":"publisher","first-page":"771\u22126","DOI":"10.4269\/ajtmh.14-0282","article-title":"Q Fever in French Guiana","volume":"91","author":"Eldin","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e39\u221242","DOI":"10.1097\/INF.0000000000002130","article-title":"Pediatric Amazonian Toxoplasmosis Caused by Atypical Strains in French Guiana, 2002-2017","volume":"38","author":"Blaizot","year":"2019","journal-title":"Pediatr Infect Dis J"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.881352\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T16:46:46Z","timestamp":1700498806000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.881352\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,26]]},"references-count":40,"alternative-id":["10.3389\/fimmu.2022.881352"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.881352","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,26]]},"article-number":"881352"}}